This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Sharecare Temettü

Temettü kriter kontrolleri 0/6

Sharecare şirketinin temettü ödeme geçmişi bulunmamaktadır.

Anahtar bilgiler

n/a

Temettü verimi

2.3%

Geri Alım Getirisi

Toplam Hissedar Getirisi	2.3%
Gelecekteki Temettü Verimi	0%
Temettü Büyümesi	n/a
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	n/a
Ödeme oranı	n/a

Son temettü güncellemeleri

Güncelleme yok

Recent updates

Sharecare awarded three-year NCQA accreditation for wellness and health promotion

Sep 19

Sharecare Non-GAAP EPS of -$0.02 beats by $0.07, revenue of $103.8M beats by $0.87M

Aug 10

Analysts Have Lowered Expectations For Sharecare, Inc. (NASDAQ:SHCR) After Its Latest Results

Apr 03

Sharecare, Inc. (NASDAQ:SHCR) Analysts Just Slashed This Year's Estimates

Apr 02

Sharecare CEO Jeff Arnold - Healthcare Ripe For Disruption (Video)

Nov 23

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: SHCR şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: SHCR şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

Sharecare Piyasaya Karşı Temettü Getirisi

SHCR temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (SHCR)	n/a
Pazarın Alt %25'i (US)	1.5%
Pazarın En İyi %25'i (US)	4.5%
Sektör Ortalaması (Healthcare Services)	1.0%
Analist tahmini (SHCR) (3 yıla kadar)	0%

Önemli Temettü: SHCR şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, SHCR şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: SHCR şirketinin temettü ödemelerinin kazançlarla karşılanıp karşılanmadığını belirlemek için ödeme oranını hesaplamak üzere yeterli veri yok.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: SHCR herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

This company has been acquired

Sharecare Temettü

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü güncellemeleri

Recent updates

Sharecare, Inc.(NasdaqGM:SHCR) dropped from NASDAQ Composite Index

Altaris, LLC completed the acquisition of Sharecare, Inc. (NasdaqGS:SHCR) from a group of shareholders.

Founder & Executive Chairman exercised options and sold US$245k worth of stock

Chief Administrative Officer recently sold US$154k worth of stock

President & CFO notifies of intention to sell stock

New minor risk - Shareholder dilution

Altaris, LLC entered into a definitive agreement to acquire Sharecare, Inc. (NasdaqGS:SHCR) for approximately $520 million.

Price target decreased by 14% to US$1.50

Sharecare, Inc., Annual General Meeting, Jun 13, 2024

Sharecare, Inc. to Report Q1, 2024 Results on May 09, 2024

Rosen Law Firm Files A Class Action Lawsuit Against Sharecare Inc

Rosen Law Firm Files A Class Action Lawsuit Against Sharecare Inc

Sharecare Receives a Letter from the Listing Qualifications Department of the Nasdaq Stock Market

Sharecare, Inc Appoints Nicole Torraco to its Board of Directors

Sharecare, Inc. announced delayed annual 10-K filing

Sharecare, Inc. to Report Q4, 2023 Results on Mar 13, 2024

Founder & Executive Chairman exercised options and sold US$216k worth of stock

Founder & Executive Chairman exercised options and sold US$660k worth of stock

We Think Sharecare (NASDAQ:SHCR) Can Afford To Drive Business Growth

Price target decreased by 10.0% to US$3.00

Sharecare, Inc. Announces CEO Changes

Third quarter 2023 earnings released: US$0.07 loss per share (vs US$0.078 loss in 3Q 2022)

Sharecare, Inc. to Report Q3, 2023 Results on Nov 09, 2023

New minor risk - Share price stability

Consensus EPS estimates fall by 12%

We're Hopeful That Sharecare (NASDAQ:SHCR) Will Use Its Cash Wisely

Second quarter 2023 earnings: EPS misses analyst expectations

Sharecare, Inc. Provides Revenue Guidance for the Third Quarter Ending September 30, 2023 and Fiscal Year Ending December 31, 2023

Sharecare Expands Suite of Customer Activation and Management Solutions to Support Patient Education and Improve the Care Journey

Sharecare, Inc. to Report Q2, 2023 Results on Aug 09, 2023

There's No Escaping Sharecare, Inc.'s (NASDAQ:SHCR) Muted Revenues

Sharecare, Inc. (NasdaqGS:SHCR) announces an Equity Buyback for $50 million worth of its shares.

Consensus EPS estimates fall by 16%

Consensus EPS estimates fall by 61%

Sharecare, Inc. Revises Revenue Guidance for the Fiscal Year Ending December 31, 2023

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Key Executive exercised options and sold US$94k worth of stock

Full year 2022 earnings: EPS misses analyst expectations

We Think Sharecare (NASDAQ:SHCR) Needs To Drive Business Growth Carefully

Sharecare Launches VR Program to Improve Well-Being of American Workforce and Bring Innovation to Exercise

Sharecare Launches Virtual Model of Its Medicare-Reimbursable Cardiac Rehabilitation Program, Ornish Lifestyle Medicine

Price target increased to US$3.50

Sharecare, Inc. Appoints Brent Layton to Its Board of Directors and Audit Committee

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Sharecare, Inc. to Report Q3, 2022 Results on Nov 10, 2022

Price target decreased to US$3.40

Sharecare Announces Nine New Digital Solutions Designed to Engage, Educate, and Support People in Managing Their Health

Sharecare Receives Three-Year NCQA Accreditation for Wellness and Health Promotion

Sharecare awarded three-year NCQA accreditation for wellness and health promotion

Sharecare Launches Self-Service Software Platform to Enable Independent Decentralized Clinical Research

Consensus EPS estimates fall by 69%

Second quarter 2022 earnings: EPS misses analyst expectations

Sharecare Non-GAAP EPS of -$0.02 beats by $0.07, revenue of $103.8M beats by $0.87M

Sharecare, Inc. to Report Q2, 2022 Results on Aug 10, 2022

Sharecare Names Harsha Panyadahundi Chief Technology Officer

Consensus forecasts updated

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Sharecare, Inc. (NasdaqGS:SHCR) announces an Equity Buyback for $50 million worth of its shares.

Sharecare Announces Sharecare+, its Whole Health, Payor-Agnostic Advocacy Solution

Price target decreased to US$6.67

Forecast breakeven date pushed back to 2023

Sharecare, Inc. to Report Q1, 2022 Results on May 12, 2022

Consensus revenue estimates fall by 12%

Analysts Have Lowered Expectations For Sharecare, Inc. (NASDAQ:SHCR) After Its Latest Results

Sharecare, Inc. (NASDAQ:SHCR) Analysts Just Slashed This Year's Estimates

Full year 2021 earnings: EPS misses analyst expectations

Sharecare, Inc. Provides Earning Guidance for the First Quarter Ending March 31, 2022 and Year Ending December 31, 2022

Sharecare, Inc. to Report Q4, 2021 Results on Mar 31, 2022

Price target decreased to US$10.50

Sharecare CEO Jeff Arnold - Healthcare Ripe For Disruption (Video)

No longer forecast to breakeven

Sharecare, Inc. (NasdaqGS:SHCR) acquired CareLinx Incorporated from Europ Assistance Holding S.A.S for $65 million.

Director Bradley Karro has left the company